Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON · Oct 27, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how a specific treatment called gamma-knife radiosurgery affects balance and inner ear function in patients with vestibular schwannoma, which is a type of tumor that can impact hearing and balance. The goal is to understand how this treatment changes vestibular function over time.

To participate in the study, you must be between 18 and 90 years old and have received gamma-knife radiosurgery for vestibular schwannoma. It's important that you have had a balance assessment before this treatment and that you are willing to take part in the study. Participants will be monitored to see how their balance and vestibular function evolve after treatment. If you have another balance condition, are unable to cooperate with the study, or do not have health insurance, you may not be eligible to join. This study is currently looking for new participants, and your involvement could help improve understanding of how this treatment works.

Gender

ALL

Eligibility criteria

• Inclusion Criteria :
• • Men and women aged 18 to 90 included
• • Subject who benefited from gamma-knife radiosurgery as part of the treatment of vestibular schwannoma
• • Non-opposition of the subject to participate in the study
• • Affiliation to a French social security scheme or beneficiary of such a scheme
• Exclusion Criteria :
• • Subject with another vestibular pathology
• • Subject who did not benefit from a vestibular assessment before treatment with gamma-knife radiosurgery
• • Legal incapacity or limited legal capacity
• • Subject unlikely to cooperate in the study and/or weak cooperation anticipated by the investigator
• • Subject without health insurance
• • Subject being in the period of exclusion from another study or provided for by the "national volunteer file".